Pricing Log in Create free account

Akari Therapeutics PLC (AKTX) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Akari Therapeutics PLC and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Akari Therapeutics PLC and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($14.0M and $13.6M). Across the 8 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 7 and Akari Therapeutics PLC on 1.

Valuation

Metric AKTX RADX Biotechnology median
P/E n/m — 10.60
P/S n/m — 9.40
P/B 0.77 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (316.53%) — (32.88%)
Free cash flow yield (75.80%) 0.00% (23.13%)

Profitability

Metric AKTX RADX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (140.09%) 0.00% (51.96%)
Return on assets (69.16%) 0.00% (46.06%)
Return on invested capital (167.93%) 0.00% 0.00%

Growth

Metric AKTX RADX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 68.99% (1.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AKTX RADX Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 0.60 1.16 4.97
Net debt to EBITDA 0.27 0.08 1.01

Dividend

Metric AKTX RADX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AKTX RADX Biotechnology median
Market cap 13.56m 13.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack